Page last updated: 2024-10-18

glycerol and Benign Neoplasms, Brain

glycerol has been researched along with Benign Neoplasms, Brain in 52 studies

Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.

Research Excerpts

ExcerptRelevanceReference
"Radiotherapy up to 10 Gy given in five fractions does not influence the glucose metabolism nor does it induce any acute cytotoxic effect detected with glutamate or glycerol in malignant glioma, as assessed by microdialysis."7.74Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. ( Bergenheim, AT; Bergström, P; Henriksson, R; Tabatabaei, P, 2008)
" In this study we show that the chemical chaperone, glycerol, and the transcriptional regulator, sodium 4-phenylbutyrate, inhibit the constitutively activated inward current and reduce cell growth and migration in glioblastoma multiforme."7.73Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells. ( Benos, DJ; Bubien, JK; Colby, G; Esimai, O; Fuller, CM; Gillespie, GY; Jovov, B; Kovacs, GG; Mapstone, TB; Markert, JM; Pahwa, AK; Vila-Carriles, WH; Zhou, ZH, 2006)
" We investigated the spatial distribution of intracarotid fluorescein sodium and intravenous lissamine-rhodamine B200 (RB 200)-albumin in the brain of normal and C6 glioma-bearing rats after intracarotid co-administration of 1-O-pentylglycerol (200 mm)."7.72Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. ( Alipour, M; Eibl, H; Erdlenbruch, B; Fricker, G; Kugler, W; Lakomek, M; Miller, DS, 2003)
"ErPC (40 mg/kg) was given to C6 glioma-bearing rats either as a single intracarotid bolus injection in the presence or absence of 1- O-pentylglycerol (300 m M) or as an intracarotid infusion in conjunction with bradykinin."7.71Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats. ( Eibl, H; Erdlenbruch, B; Jendrossek, V; Kugler, W; Lakomek, M, 2002)
"Paclitaxel (Taxol), an anti-cancer drug derived from Taxus species, was tested for its anti-migrational, anti-invasive and anti-proliferative effect on two human glioma cell lines (GaMg and D-54Mg) grown as multicellular tumour spheroids."7.69Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. ( Arnold, H; Bjerkvig, R; Dahl, O; Gundersen, G; Heese, O; Terzis, AJ; Thorsen, F; Visted, T, 1997)
"Curcumin has multiple biological and pharmacological activities, including antioxidant, anti-inflammatory, antiviral, antibacterial, antifungal, and antitumor activities."5.39A poly(glycerol-sebacate-curcumin) polymer with potential use for brain gliomas. ( Dong, DL; Lu, XL; Sun, B; Sun, ZJ; Tao, RB; Xie, X, 2013)
"To evaluate the effect of glycerol, thirty-two patients with brain tumor were directed to the study, including 17 gliomas and 15 meningiomas."5.08Effect of glycerol on blood flow distribution in tumoral and peritumoral brain tissue. ( Furuse, M; Ichimi, K; Inao, S; Ishikawa, Y; Kawai, T; Kuchiwaki, H; Niwa, M; Oyama, H; Shibayama, M; Takada, S, 1997)
"Forty-four patients with metastatic brain neoplasms received glycerol instead of corticosteroids during periods of brain irradiation."5.05Glycerol: an alternative to dexamethasone for patients receiving brain irradiation for metastatic disease. ( Bedikian, AY; Bodey, GP; Freireich, EJ; Heilbrun, LK; Valdivieso, M; Withers, RH, 1980)
"Radiotherapy up to 10 Gy given in five fractions does not influence the glucose metabolism nor does it induce any acute cytotoxic effect detected with glutamate or glycerol in malignant glioma, as assessed by microdialysis."3.74Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. ( Bergenheim, AT; Bergström, P; Henriksson, R; Tabatabaei, P, 2008)
" In this study we show that the chemical chaperone, glycerol, and the transcriptional regulator, sodium 4-phenylbutyrate, inhibit the constitutively activated inward current and reduce cell growth and migration in glioblastoma multiforme."3.73Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells. ( Benos, DJ; Bubien, JK; Colby, G; Esimai, O; Fuller, CM; Gillespie, GY; Jovov, B; Kovacs, GG; Mapstone, TB; Markert, JM; Pahwa, AK; Vila-Carriles, WH; Zhou, ZH, 2006)
" We investigated the spatial distribution of intracarotid fluorescein sodium and intravenous lissamine-rhodamine B200 (RB 200)-albumin in the brain of normal and C6 glioma-bearing rats after intracarotid co-administration of 1-O-pentylglycerol (200 mm)."3.72Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. ( Alipour, M; Eibl, H; Erdlenbruch, B; Fricker, G; Kugler, W; Lakomek, M; Miller, DS, 2003)
"ErPC (40 mg/kg) was given to C6 glioma-bearing rats either as a single intracarotid bolus injection in the presence or absence of 1- O-pentylglycerol (300 m M) or as an intracarotid infusion in conjunction with bradykinin."3.71Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats. ( Eibl, H; Erdlenbruch, B; Jendrossek, V; Kugler, W; Lakomek, M, 2002)
"Paclitaxel (Taxol), an anti-cancer drug derived from Taxus species, was tested for its anti-migrational, anti-invasive and anti-proliferative effect on two human glioma cell lines (GaMg and D-54Mg) grown as multicellular tumour spheroids."3.69Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. ( Arnold, H; Bjerkvig, R; Dahl, O; Gundersen, G; Heese, O; Terzis, AJ; Thorsen, F; Visted, T, 1997)
"The effect of glycerol on blood flow in tumoral and peritumoral tissue was measured in 32 patients with brain tumor, 17 gliomas and 15 meningiomas."3.69Effect of glycerol on blood flow distribution in tumoral and peritumoral brain tissue. ( Furuse, M; Inao, S; Kida, Y; Kobayashi, T; Maesawa, S; Niwa, M; Oyama, H; Tanaka, T; Yoshida, J, 1997)
" She received glycerol solution to treat the brain edema and recovered completely from the encephalopathy."3.68Treatment of malignant glioma with high dose intra-arterial ACNU and autologous bone marrow transplantation--case report. ( Fujiwara, T; Ohmoto, T; Yoshioka, J, 1991)
"Twenty-six patients with intracerebral tumors (predominantly gliomas) were treated with intraarterial BCNU, VM-26, and cisplatin combined with the systemic administration of VM-26, methotrexate, vincristine, bleomycin, and procarbazine."3.67Combined intraarterial and systemic chemotherapy for intracerebral tumors. ( Benoit, B; Grahovac, Z; Hugenholtz, H; Richard, M; Russell, N; Stewart, DJ, 1987)
"Thirty-three patients with metastatic brain neoplasms of various types received glycerol instead of corticosteroids during periods of brain irradiation."3.66Glycerol: a successful alternative to dexamethasone for patients receiving brain irradiation for metastatic disease. ( Bedikian, AY; Benjamin, RS; Bodey, GP; Freireich, EJ; Gutterman, JU; Heilbrun, LK; Valdivieso, M; Withers, RH, 1978)
"A patient with glioblastoma multiforme of the brain was treated with both intravenous and oral glycerol as well as intravenous mannitol in an attempt to reduce increased intracranial pressure."3.65Rebound phenomenon complicating cerebral dehydration with glycerol. Case report. ( Arieff, AI; Guisado, R; Mishra, SK; Schotz, MC; Tomiyasu, U; Tourtellotte, WW, 1975)
"Sixteen patients with intracerebral tumors received intraarterial cisplatin, teniposide, and BCNU combined with intravenous cisplatin, teniposide, and cytosine arabinoside."2.67Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. ( Belanger, G; Benoit, B; DaSilva, V; Grahovac, Z; Hugenholtz, H; Richard, MT; Russell, N; Stewart, DJ, 1993)
"Glioblastoma is a highly aggressive brain tumor."1.46Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome. ( Auslander, N; Ben-Shushan, D; Calderón, M; Eldar-Boock, A; Ferber, S; Grossman, R; Haag, R; Henkin, J; Krivitsky, A; Licha, K; Ofek, P; Ram, Z; Ruppin, E; Satchi-Fainaro, R; Scomparin, A; Sousa-Herves, A; Tiram, G; Vossen, LI; Yeini, E, 2017)
"Curcumin has multiple biological and pharmacological activities, including antioxidant, anti-inflammatory, antiviral, antibacterial, antifungal, and antitumor activities."1.39A poly(glycerol-sebacate-curcumin) polymer with potential use for brain gliomas. ( Dong, DL; Lu, XL; Sun, B; Sun, ZJ; Tao, RB; Xie, X, 2013)
" Body weight change and neutropenia were assessed as pharmacodynamic markers of toxicity."1.36Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model. ( Harrold, JM; Mager, DE; Mazurchuk, RV; Straubinger, RM; Tamburlin, JH; Zhou, R, 2010)
"Paclitaxel has been shown to be active against gliomas and various brain metastases."1.32Paclitaxel nanoparticles for the potential treatment of brain tumors. ( Allen, DD; Koziara, JM; Lockman, PR; Mumper, RJ, 2004)
"Brain metastasis from ovarian cancer, a rare and highly dismal event, develops mostly during or after postoperative chemotherapy."1.30Brain metastasis as first manifestation of ovarian cancer. ( Imai, A; Matsunami, K; Noda, K; Takagi, H; Tamaya, T, 1999)
"Concentrations were comparable in brain metastases and meningiomas (3 patients)."1.27Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol. ( Dennery, J; Hopkins, HS; Hugenholtz, H; Montpetit, V; Nundy, D; Prior, J; Richard, MT; Stewart, DJ, 1984)
"In the patient with brain tumors with marked brain edema (group A, 11 studies), EEG topography showed marked reduction of delta focus within 20 minutes from the end of intravenous infusion of glycerol, and returned to preinfusion distribution within 60 minutes."1.27[The effect of glycerol on EEG-abnormality (polymorphic delta wave) in patients with brain tumors]. ( Ishikawa, T; Matsuoka, S; Okuda, S; Soejima, T, 1987)

Research

Studies (52)

TimeframeStudies, this research(%)All Research%
pre-199023 (44.23)18.7374
1990's10 (19.23)18.2507
2000's8 (15.38)29.6817
2010's9 (17.31)24.3611
2020's2 (3.85)2.80

Authors

AuthorsStudies
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q5
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C3
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J2
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L2
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z3
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X2
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X4
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X4
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E2
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Tabatabaei, P3
Asklund, T1
Bergström, P4
Björn, E1
Johansson, M1
Bergenheim, AT6
Gaudin, A1
King, AR1
Seo, YE1
Suh, HW1
Deng, Y1
Tietjen, GT1
Huttner, A1
Saltzman, WM1
Ferber, S2
Tiram, G2
Sousa-Herves, A1
Eldar-Boock, A1
Krivitsky, A2
Scomparin, A1
Yeini, E1
Ofek, P2
Ben-Shushan, D1
Vossen, LI1
Licha, K1
Grossman, R2
Ram, Z2
Henkin, J1
Ruppin, E1
Auslander, N1
Haag, R2
Calderón, M2
Satchi-Fainaro, R2
Li, TF1
Li, K1
Yue, Y1
Yuan, SJ1
Wen, Y1
Han, M1
Komatsu, N1
Xu, YH1
Kaushik, NK1
Attri, P1
Kaushik, N1
Choi, EH1
Mehrabadi, FS1
Yerushalmi, N1
Kredo-Russo, S1
Visse, E1
Brännström, T1
Siesjö, P1
Henriksson, R3
Lindvall, P1
Roslin, M3
Zhou, R1
Mazurchuk, RV1
Tamburlin, JH1
Harrold, JM1
Mager, DE1
Straubinger, RM1
Sun, ZJ1
Sun, B1
Tao, RB1
Lu, XL1
Dong, DL1
Erdlenbruch, B2
Jendrossek, V1
Kugler, W2
Eibl, H2
Lakomek, M2
Ungerstedt, U2
CANTORE, G1
GUIDETTI, B2
VIRNO, M3
Alipour, M1
Fricker, G1
Miller, DS1
Koziara, JM1
Lockman, PR1
Allen, DD1
Mumper, RJ1
Vila-Carriles, WH1
Kovacs, GG1
Jovov, B1
Zhou, ZH1
Pahwa, AK1
Colby, G1
Esimai, O1
Gillespie, GY1
Mapstone, TB1
Markert, JM1
Fuller, CM1
Bubien, JK1
Benos, DJ1
Waldenström, A1
Ronquist, G1
Stewart, DJ3
Richard, MT2
Hugenholtz, H3
Dennery, J1
Nundy, D1
Prior, J1
Montpetit, V1
Hopkins, HS1
Marshall, LF1
Matarese, RM1
Zamponi, C1
Bedikian, AY2
Valdivieso, M2
Heilbrun, LK2
Withers, RH2
Bodey, GP2
Freireich, EJ2
Metzel, E1
Rudolph, E1
Schönleber, G1
Moriyama, T1
Saito, K1
Julow, J1
Sato, S3
Suga, S2
Yunoki, K1
Mihara, B1
Grahovac, Z2
DaSilva, V1
Benoit, B2
Belanger, G1
Russell, N2
Terzis, AJ1
Thorsen, F1
Heese, O1
Visted, T1
Bjerkvig, R1
Dahl, O1
Arnold, H1
Gundersen, G1
Niwa, M2
Oyama, H2
Kobayashi, T1
Kida, Y1
Tanaka, T1
Maesawa, S1
Furuse, M2
Inao, S2
Yoshida, J1
Takada, S1
Kawai, T1
Ishikawa, Y1
Kuchiwaki, H1
Ichimi, K1
Shibayama, M1
Thalacker, U1
Liszka, G1
Somogyi, A1
Németh, G1
Matsunami, K1
Imai, A1
Tamaya, T1
Takagi, H1
Noda, K1
Hartmann, A1
Lange, D1
Alberti, E1
Dorndorf, W1
Guisado, R1
Tourtellotte, WW1
Arieff, AI1
Tomiyasu, U1
Mishra, SK1
Schotz, MC1
Yoneda, S1
Matsuda, M1
Goto, H1
Handa, J2
Handa, H2
Benjamin, RS1
Gutterman, JU1
Gaab, M1
Pflughaupt, KW1
Oppido, PA1
Delfini, R1
Innocenzi, G1
Di Giugno, G1
Pecori-Giraldi, J2
Santoro, A1
Cantore, GP2
Fujiwara, T1
Yoshioka, J1
Ohmoto, T1
Toya, S2
Ohtani, M1
Harada, S1
Ikeda, Y1
Richard, M1
Otani, M1
Soejima, T1
Okuda, S1
Ishikawa, T1
Matsuoka, S1
Ishikawa, M1
Hirakawa, K1
Nakamura, T1
Fukuma, S1
Hakusui, S1
Taketomo, S1
Odawara, K1
Nisimura, T1
Meyer, JS2
Charney, JZ1
Rivera, VM1
Mathew, NT2
Hägnevik, K1
Gordon, E1
Lins, LE1
Wilhelmsson, S1
Forster, D1
Kirsch, WM1
Schulz, D1
Nakane, P1
Lasher, R1
Yamamoto, T1
Fukuuchi, Y1
Shimazu, K1
Ouchi, T1
Pigossi, N1
Raia, A1
Lex, A1
Gama, AH1
Simonsen, O1
Haddad, J1
Stolf, NA1
Zerbini, EJ1
Miniti, A1
Tenuto, R1
Thierry, A1
Dechaume, JP1
Friedel, M1
Plasse, JC1
Martinet, R1
Mansuy, L1
de Vocht, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Role of Glutamate-mediate Excitotoxicity in Invasion and Progression Processes of Glioblastoma Multiforme[NCT05775458]50 participants (Anticipated)Observational2020-06-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for glycerol and Benign Neoplasms, Brain

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016

Trials

5 trials available for glycerol and Benign Neoplasms, Brain

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).
    Journal of neuro-oncology, 2006, Volume: 80, Issue:3

    Topics: Aged; Aminobutyrates; Antimetabolites, Antineoplastic; Brain Neoplasms; Catheters, Indwelling; Dose-

2006
Glycerol: an alternative to dexamethasone for patients receiving brain irradiation for metastatic disease.
    Southern medical journal, 1980, Volume: 73, Issue:9

    Topics: Brain Neoplasms; Clinical Trials as Topic; Dexamethasone; Glycerol; Humans; Intracranial Pressure; R

1980
Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
    Journal of neuro-oncology, 1993, Volume: 17, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin;

1993
Effect of glycerol on blood flow distribution in tumoral and peritumoral brain tissue.
    Acta neurochirurgica. Supplement, 1997, Volume: 70

    Topics: Brain Neoplasms; Cerebrovascular Circulation; Glioma; Glycerol; Humans; Meningeal Neoplasms; Meningi

1997

Other Studies

47 other studies available for glycerol and Benign Neoplasms, Brain

ArticleYear
Intratumoral retrograde microdialysis treatment of high-grade glioma with cisplatin.
    Acta neurochirurgica, 2020, Volume: 162, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain; Brain Neoplasms; Cisplatin; Female; Gl

2020
Surface chemistry governs cellular tropism of nanoparticles in the brain.
    Nature communications, 2017, 05-19, Volume: 8

    Topics: Animals; Brain; Brain Neoplasms; Cell Line; Cell Line, Tumor; Central Nervous System; Drug Delivery

2017
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.
    eLife, 2017, 10-04, Volume: 6

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Drug Carriers; Drug Synergism; Drug Therapy; Gliobl

2017
Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
    Biomaterials, 2018, Volume: 181

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dendritic Cells; Doxorubicin; Drug Carrie

2018
A preliminary study of the effect of DBD plasma and osmolytes on T98G brain cancer and HEK non-malignant cells.
    Molecules (Basel, Switzerland), 2013, Apr-25, Volume: 18, Issue:5

    Topics: Brain Neoplasms; Cell Line, Tumor; Cryoprotective Agents; Glycerol; HEK293 Cells; Humans; Methylamin

2013
Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex.
    Nanomedicine : nanotechnology, biology, and medicine, 2016, Volume: 12, Issue:7

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Carriers; Gliobl

2016
Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.
    Journal of neuro-oncology, 2017, Volume: 131, Issue:1

    Topics: Aged; Aged, 80 and over; Brain Neoplasms; Cytokines; Female; Glioma; Glucose; Glutamic Acid; Glycero

2017
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:1

    Topics: Brain Neoplasms; Glioma; Glucose; Glutamic Acid; Glycerol; Humans; Microdialysis; Radiosurgery

2008
Cerebral metabolism during air transport of patients after surgery for malignant glioma.
    Aviation, space, and environmental medicine, 2008, Volume: 79, Issue:7

    Topics: Air Ambulances; Brain; Brain Neoplasms; Glioma; Glucose; Glutamic Acid; Glycerol; Humans; Lactic Aci

2008
Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Brain Neoplasms; Chemistry, Pharmaceutical;

2010
A poly(glycerol-sebacate-curcumin) polymer with potential use for brain gliomas.
    Journal of biomedical materials research. Part A, 2013, Volume: 101, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Death; Cell Line, Tumor; Curcumin; Decanoates;

2013
Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:4

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Glioma; Glycerol; Injec

2002
Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis.
    Journal of neuro-oncology, 2003, Volume: 61, Issue:2

    Topics: Aged; Astrocytoma; Biopsy; Brain Neoplasms; Female; Glucose; Glutamates; Glycerol; Humans; In Vitro

2003
ORAL GLYCEROL FOR THE REDUCTION OF INTRACRANIAL PRESSURE.
    Journal of neurosurgery, 1964, Volume: 21

    Topics: Brain Edema; Brain Neoplasms; Cerebral Cortex; Cerebrospinal Fluid; Craniocerebral Trauma; Drug Ther

1964
Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
    British journal of pharmacology, 2003, Volume: 140, Issue:7

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blood-Brain Barrier; Brain; Brain Neoplasms; Capi

2003
Paclitaxel nanoparticles for the potential treatment of brain tumors.
    Journal of controlled release : official journal of the Controlled Release Society, 2004, Sep-30, Volume: 99, Issue:2

    Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Sur

2004
Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells.
    The Journal of biological chemistry, 2006, Jul-14, Volume: 281, Issue:28

    Topics: Acid Sensing Ion Channels; Amiloride; Antineoplastic Agents; Brain Neoplasms; Cell Membrane; Cell Mo

2006
Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.
    Journal of neuro-oncology, 1984, Volume: 2, Issue:4

    Topics: Amphotericin B; Astrocytoma; Brain Neoplasms; Glycerol; Humans; Kinetics; Meningioma; Podophyllotoxi

1984
Treatment of brain swelling and brain edema in man.
    Advances in neurology, 1980, Volume: 28

    Topics: Barbiturates; Brain Edema; Brain Ischemia; Brain Neoplasms; Cerebral Infarction; Dexamethasone; Diur

1980
Determination of glycerol in biological samples.
    Journal of chromatography, 1983, Apr-08, Volume: 273, Issue:2

    Topics: Brain Neoplasms; Erythritol; Glycerol; Humans

1983
[Therapeutic possibilities of influencing brain oedema by the action of glycerin (author's transl)].
    Neurochirurgia, 1981, Volume: 24, Issue:1

    Topics: Brain Edema; Brain Neoplasms; Glycerol; Humans; Preoperative Care

1981
[A role of glycerol in contrast enhancement (author's transl)].
    No shinkei geka. Neurological surgery, 1980, Volume: 8, Issue:12

    Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Contrast Media; Extravasation of Diagnostic and The

1980
Effect of barrier opening on brain edema in human brain tumors.
    Acta neurochirurgica. Supplementum, 1994, Volume: 60

    Topics: Adult; Astrocytoma; Blood-Brain Barrier; Brain; Brain Concussion; Brain Edema; Brain Neoplasms; Fema

1994
Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.
    British journal of cancer, 1997, Volume: 75, Issue:12

    Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Division; Cell Movement; Fe

1997
Effect of glycerol on blood flow distribution in tumoral and peritumoral brain tissue.
    Neurologia medico-chirurgica, 1997, Volume: 37, Issue:11

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Cerebrovascular Circulation; Female; Glioma; Glycerol; Hum

1997
[The observation of edema in the substantia alba during postoperative brain irradiation. The role of computed tomographic studies].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1998, Volume: 174, Issue:1

    Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Diuretics; Drug Therapy, Combination; Furosemide; Glycero

1998
Brain metastasis as first manifestation of ovarian cancer.
    European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 82, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Endometrioid; Cis

1999
[Estimation of regional cerebral blood flow with the gamma-camera (author's transl)].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1977, Volume: 126, Issue:1

    Topics: Brain Edema; Brain Neoplasms; Cerebral Angiography; Cerebrovascular Circulation; Diagnosis, Computer

1977
Rebound phenomenon complicating cerebral dehydration with glycerol. Case report.
    Journal of neurosurgery, 1975, Volume: 42, Issue:2

    Topics: Administration, Oral; Brain Neoplasms; Glioblastoma; Glycerol; Humans; Injections, Intravenous; Intr

1975
[The effects of glycerol and mannitol on the epidural intracranial presssure of the patients with increased intracranial pressure (author's transl)].
    Nihon geka hokan. Archiv fur japanische Chirurgie, 1977, Nov-01, Volume: 46, Issue:6

    Topics: Adult; Astrocytoma; Brain Neoplasms; Dura Mater; Female; Glioma; Glycerol; Humans; Intracranial Pres

1977
Glycerol: a successful alternative to dexamethasone for patients receiving brain irradiation for metastatic disease.
    Cancer treatment reports, 1978, Volume: 62, Issue:7

    Topics: Brain Neoplasms; Dexamethasone; Drug Evaluation; Glycerol; Humans; Neoplasm Metastasis; Pilot Projec

1978
[Experimental and clinical investigations on the treatment of brain edema by intravenous glycerin administration].
    Acta neurochirurgica, 1977, Volume: 37, Issue:1-2

    Topics: Animals; Brain Edema; Brain Neoplasms; Dexamethasone; Glioma; Glycerol; Hematoma, Subdural; Humans;

1977
Brain oedema and intracranial hypertension treatment by GLIAS.
    Acta neurochirurgica. Supplementum, 1992, Volume: 55

    Topics: Adolescent; Adult; Aged; Ascorbic Acid; Brain Edema; Brain Injuries; Brain Neoplasms; Buffers; Cereb

1992
Treatment of malignant glioma with high dose intra-arterial ACNU and autologous bone marrow transplantation--case report.
    Neurologia medico-chirurgica, 1991, Volume: 31, Issue:10

    Topics: Adult; Agranulocytosis; Astrocytoma; Bone Marrow Transplantation; Brain Edema; Brain Neoplasms; Comb

1991
Effect of blood-brain barrier disruption on the permeability of peritumoral edema.
    Advances in neurology, 1990, Volume: 52

    Topics: Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Glycerol; Humans; Mannitol

1990
Combined intraarterial and systemic chemotherapy for intracerebral tumors.
    Neurosurgery, 1987, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms;

1987
[Blood-brain barrier opening microcirculation in human brain tumor].
    No to shinkei = Brain and nerve, 1985, Volume: 37, Issue:2

    Topics: Aged; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Female; Glioblastoma; Glycerol; Humans; Hyp

1985
[The effect of glycerol on EEG-abnormality (polymorphic delta wave) in patients with brain tumors].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:6

    Topics: Adult; Aged; Brain; Brain Edema; Brain Neoplasms; Delta Rhythm; Electroencephalography; Female; Glyc

1987
[Clinical analysis of long-term administration of Glyceol].
    Nihon geka hokan. Archiv fur japanische Chirurgie, 1986, Jul-01, Volume: 55, Issue:4

    Topics: Aged; Analysis of Variance; Brain Neoplasms; Cerebrovascular Disorders; Drug Administration Schedule

1986
Treatment with glycerol of cerebral oedema due to acute cerebral infarction.
    Lancet (London, England), 1971, Volume: 2, Issue:7732

    Topics: Administration, Oral; Adult; Aged; Autopsy; Brain Edema; Brain Neoplasms; Cerebral Angiography; Cere

1971
Glycerol-induced haemolysis with haemoglobinuria and acute renal failure. Report of three cases.
    Lancet (London, England), 1974, Jan-19, Volume: 1, Issue:7847

    Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Brain Edema; Brain Neoplasms; Female; Glycer

1974
Isolation and characterization of glioblastoma nuclei and chromosomes in the lyophilized state.
    Journal of neurosurgery, 1971, Volume: 34, Issue:3

    Topics: Adenosine Triphosphate; Animals; Brain Chemistry; Brain Neoplasms; Cell Nucleus; Centrifugation; Chr

1971
Effect of regional cerebral blood flow of compression by a mass lesion.
    European neurology, 1972, Volume: 8, Issue:1

    Topics: Animals; Brain; Brain Edema; Brain Injuries; Brain Neoplasms; Carbon Dioxide; Cerebral Hemorrhage; C

1972
[Experimental and clinical study on the use as a transplant of homogenous dura mater preserved in glycerin at room temperature].
    AMB : revista da Associacao Medica Brasileira, 1971, Volume: 17, Issue:8

    Topics: Adult; Animals; Brain Neoplasms; Dogs; Dura Mater; Ear Diseases; Glycerol; Humans; Male; Methods; Pe

1971
[Use of glycerol per os in the fundamental treatment of intracranial hypertension].
    Journal de medecine de Lyon, 1966, Oct-05, Volume: 47, Issue:106

    Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Child; Female; Glycerol; Humans; Intracranial Pressure; M

1966
[Intravenous glycerol in the treatment of intracranial hypertension. (Preliminary note)].
    Il Policlinico. Sezione pratica, 1966, Apr-25, Volume: 73, Issue:17

    Topics: Adolescent; Adult; Aged; Brain Diseases; Brain Edema; Brain Neoplasms; Female; Glycerol; Humans; Inj

1966
Misinterpretations in inferences on the causal contribution of cell phones to brain tumour incidence in South Korea: Response to Moon (2023).
    Environmental research, 2023, 11-01, Volume: 236, Issue:Pt 2

    Topics: Brain Neoplasms; Cell Phone; Humans; Incidence; Moon; Republic of Korea

2023